|

YL211 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • MediLink Therapeutics (Suzhou) Co., Ltd.1

Indications

  • Advanced Solid Tumors1
  • Cancer1

Aurora, Colorado1 trial

A Phase I Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors

University of Colorado Hospital - Anschutz Cancer Pavilion

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.